NCT01238679View on ClinicalTrials.gov

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PF-04958242 in Healthy Adult Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 24, 2010

Primary Completion Date

May 3, 2011

Study Completion Date

May 3, 2011

Conditions
Healthy Volunteers
Interventions
DRUG

PF-04958242

Administered as specified in the treatment arm

DRUG

Placebo

Administered as specified in the treatment arm

Trial Locations (1)

188770

Research Site, Singapore

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT01238679 - Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PF-04958242 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter